By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Nodality, Inc. 

7000 Shoreline Court
Suite 250
South San Francisco  California  94080  U.S.A.
Phone: 650-827-8000 Fax: 650-827-8001


SEARCH JOBS



Segment
Start Up





Company News
Nodality, Inc. Launches Pathpro T Cell Receptor (TCR) And B Cell Receptor (BCR) Panels For Assessing Drug Impact On Functional Signaling In Primary Human Cells 5/6/2015 11:17:29 AM
Nodality, Inc. Publishes Study Results Confirming The Company’s Diagnostic Can Predict Induction Therapy Response In Elderly Patients With Acute Myeloid Leukemia 4/21/2015 11:11:32 AM
Nodality, Inc. Launches PathPro Chronic Lymphocytic Leukemia (CLL) Panels Based On Leading Single Cell Network Profiling (SCNPTM) Platform To Enhance Pharmaceutical R&D 4/3/2015 9:13:18 AM
Nodality, Inc. Presents Data From Immuno-Oncology Program Applying Company’s Novel Single Cell Network Profiling (SCNP) Platform 2/25/2015 10:53:40 AM
Nodality, Inc. Launches Pathpro™ Product Line Based On Leading Single Cell Network Profiling (SCNPTM) Platform To Enhance Pharmaceutical R&D 1/7/2015 11:06:45 AM
Nodality, Inc. Develops Disease-Associated PD-1 Assay System For Application In Immuno-oncology 11/19/2014 5:15:42 PM
Nodality, Inc. Announces Data Presentation From Collaborative Program With UCB Pharma (UCBJF.PK) At American College of Rheumatology 2014 Annual Meeting 11/18/2014 4:45:33 PM
Nodality, Inc. Announces Data Presentations From Systemic Lupus Erythematosus Collaborative Programs At American College of Rheumatology 2014 Annual Meeting 11/17/2014 5:09:20 PM
Nodality, Inc. Expands Intellectual Property Estate, Announces U.S. Patent For Broadly Enabling Single Cell Network Profiling (SCNP) Technology Platform 8/14/2014 8:03:25 AM
Nodality, Inc. Announces Publication Of Promising Data In Melanoma In Journal Of Translational Medicine 5/28/2014 10:06:00 AM
123
//-->